Legal status by country
Is Gpld1 legal?
Written by Aaron CuhaReviewed Sep 2026
How Gpld1 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Research use only; not approved | Research use only; not licensed | Research use only; not registered | Research use only; not approved |
| Note | None recorded | None recorded | None recorded | None recorded |
US FDA status: Not approved and never administered to a human. No interventional trial of Gpld1 is registered for any indication. The only registered human study using it is observational.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.